Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-20-063476

CFO & COO sold 1,250 shares at $25.00 ($31,250)

  • CFO & COO acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GRAY MICHAEL · CFO & COO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-11 Exercise or conversion : show line 1 in the form +1,250 $4.92 $6,150 1,250 D
2020-12-11 Sale : show line 2 in the form −1,250 $25.00 $31,250 0 D
Open-market sales · 1,250 sh · avg $25.00 · $31,250

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-11 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −1,250 223,059 D
Loading xslF345X03/doc4.xml…